AMIODARONE USE IN PATIENTS LISTED FOR HEART TRANSPLANT IS ASSOCIATED WITH INCREASED ONE-YEAR POST-TRANSPLANT MORTALITY

INTRODUCTION: Pre-transplant amiodarone use has been postulated as a risk factor for morbidity and mortality after orthotopic heart transplant (OHT). We assessed pre-OHT amiodarone use and tested the hypothesis that it is associated with impaired post-OHT outcomes. METHODS: We performed a retrospect...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Heart Lung Transplant
Main Authors: Cooper, Lauren B., Mentz, Robert J., Edwards, Leah B., Wilk, Amber R., Rogers, Joseph G., Patel, Chetan B., Milano, Carmelo A., Hernandez, Adrian F., Stehlik, Josef, Lund, Lars H.
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5241253/
https://ncbi.nlm.nih.gov/pubmed/27520780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.healun.2016.07.009
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares